The provision of a Residential Substance Use Medically Managed Detoxification Service

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-029539-2021-02-23T08:45:55Z",
    "date": "2021-02-23T08:45:55Z",
    "ocid": "ocds-h6vhtk-029539",
    "initiationType": "tender",
    "tender": {
        "id": "DN509399",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "The provision of a Residential Substance Use Medically Managed Detoxification Service",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85000000",
            "description": "Health and social work services"
        },
        "mainProcurementCategory": "services",
        "description": "The purpose of the residential medically managed detoxification service is to provide a safe, evidence based,effective detoxification and stabilisation programme to aid the recovery and reintegration of substance misuserswith complex needs. Within Sefton Integrated Substance Misuse Treatment Service, the first-line detoxification offer is communitydetoxification within the adult treatment service. Where increased risk is indicated, residential in-patientdetoxification may be the safest and most effective treatment plan. Medical input and supervision can beprovided by a community GP overseeing the detoxification plan. However, medically managed inpatient detoxification is an important treatment option for service users who: * Have not benefited from previous formal community-based and/or medically supervised inpatientdetoxification * Need 24 hour specialist substance misuse medical and/or nursing care because of significant co-morbidphysical or mental health problems * Require complex polydrug detoxification, for example concurrent detoxification from alcohol orbenzodiazepines * Are experiencing significant vulnerabilities or social problems that will limit the benefit of community-baseddetoxification * Have complex needs that require admission for medical stabilisation. The particular aims of the service are * To provide a safe period of medically managed and monitored (by exception) withdrawal and detoxification, with24 hour medical supervision * To encourage, educate, motivate and enable realistic lifestyle changes * To ensure that treatment gains are maintained by developing robust links with aftercare support available withinthe community, including mental health services * To address the safeguarding and welfare needs of vulnerable adult service users or the children of substancemisusing parents, ensuring that needs are identified and planned for prior to a person's discharge from inpatientcare * To ensure that the principles of harm minimisation underpin the delivery of all interventions in order to reducethe harm caused by drugs and alcohol on individuals, thereby contributing to a reduction in drug and alcoholrelated deaths and the transmission of blood borne viruses. This procurement is being undertaken in accordance with section 7 of the Public Contracts Regulations 2015,also know as the \"Light Touch\" regime under the EU Procurement Directives.",
        "lots": [
            {
                "id": "1",
                "description": "The purpose of the residential medically managed detoxification service is to provide a safe, evidence based,effective detoxification and stabilisation programme to aid the recovery and reintegration of substance misuserswith complex needs. Within Sefton Integrated Substance Misuse Treatment Service, the first-line detoxification offer is communitydetoxification within the adult treatment service. Where increased risk is indicated, residential in-patientdetoxification may be the safest and most effective treatment plan. Medical input and supervision can beprovided by a community GP overseeing the detoxification plan. However, medically managed inpatient detoxification is an important treatment option for service users who: * Have not benefited from previous formal community-based and/or medically supervised inpatientdetoxification * Need 24 hour specialist substance misuse medical and/or nursing care because of significant co-morbidphysical or mental health problems * Require complex polydrug detoxification, for example concurrent detoxification from alcohol orbenzodiazepines * Are experiencing significant vulnerabilities or social problems that will limit the benefit of community-baseddetoxification * Have complex needs that require admission for medical stabilisation. The particular aims of the service are * To provide a safe period of medically managed and monitored (by exception) withdrawal and detoxification, with24 hour medical supervision * To encourage, educate, motivate and enable realistic lifestyle changes * To ensure that treatment gains are maintained by developing robust links with aftercare support available withinthe community, including mental health services * To address the safeguarding and welfare needs of vulnerable adult service users or the children of substancemisusing parents, ensuring that needs are identified and planned for prior to a person's discharge from inpatientcare * To ensure that the principles of harm minimisation underpin the delivery of all interventions in order to reducethe harm caused by drugs and alcohol on individuals, thereby contributing to a reduction in drug and alcoholrelated deaths and the transmission of blood borne viruses.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Quality",
                            "type": "quality",
                            "description": "60"
                        },
                        {
                            "name": "Social Value",
                            "type": "quality",
                            "description": "10"
                        },
                        {
                            "type": "price",
                            "description": "30"
                        }
                    ]
                },
                "hasOptions": true,
                "options": {
                    "description": "There are 2 options to extend, both for 12 months each following the 5 year core period"
                },
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKD"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ]
    },
    "awards": [
        {
            "id": "003537-2021-1-1",
            "relatedLots": [
                "1"
            ],
            "title": "The provision of a Residential Substance Use Medically Managed Detoxification Service",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-6374",
                    "name": "MerseyCare NHS Trust"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-5701",
            "name": "Sefton Council",
            "identifier": {
                "legalName": "Sefton Council"
            },
            "address": {
                "streetAddress": "1st Floor Magdalen House, Trinity Road",
                "locality": "Bootle",
                "region": "UKD",
                "postalCode": "L20 3NJ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mr Stuart Bate",
                "telephone": "+44 1519344288",
                "email": "stuart.bate@sefton.gov.uk",
                "faxNumber": "+44 1519344579"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.sefton.gov.uk/",
                "buyerProfile": "http://www.sefton.gov.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "REGIONAL_AUTHORITY",
                        "description": "Regional or local authority"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "01",
                        "description": "General public services"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-6374",
            "name": "MerseyCare NHS Trust",
            "identifier": {
                "legalName": "MerseyCare NHS Trust"
            },
            "address": {
                "locality": "Huyton",
                "region": "UKD",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-6375",
            "name": "Sefton Council",
            "identifier": {
                "legalName": "Sefton Council"
            },
            "address": {
                "locality": "Bootle",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-5701",
        "name": "Sefton Council"
    },
    "contracts": [
        {
            "id": "003537-2021-1-1",
            "awardID": "003537-2021-1-1",
            "title": "The provision of a Residential Substance Use Medically Managed Detoxification Service",
            "status": "active",
            "dateSigned": "2021-02-02T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "5",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "6",
                "measure": "smeBids",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "7",
                "measure": "foreignBidsFromEU",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "8",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "1",
                "value": 0
            },
            {
                "id": "9",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "3",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 1951960,
                "currency": "GBP"
            },
            {
                "id": "4",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 3000000,
                "currency": "GBP"
            },
            {
                "id": "1",
                "measure": "lowestValidBidValue",
                "value": 1951000,
                "currency": "GBP"
            },
            {
                "id": "2",
                "measure": "highestValidBidValue",
                "value": 3000000,
                "currency": "GBP"
            }
        ]
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:552002-2020:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}